The Clorox Company (NYSE:CLX) Shares Purchased by Ashton Thomas Private Wealth LLC

Ashton Thomas Private Wealth LLC raised its position in The Clorox Company (NYSE:CLXFree Report) by 7.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,234 shares of the company’s stock after purchasing an additional 496 shares during the quarter. Ashton Thomas Private Wealth LLC’s holdings in Clorox were worth $1,175,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in CLX. QRG Capital Management Inc. acquired a new position in Clorox during the 3rd quarter worth about $225,000. Principal Financial Group Inc. increased its stake in Clorox by 6.9% during the third quarter. Principal Financial Group Inc. now owns 151,257 shares of the company’s stock worth $24,641,000 after purchasing an additional 9,720 shares during the period. CWA Asset Management Group LLC purchased a new stake in Clorox during the third quarter worth about $449,000. Lindbrook Capital LLC lifted its position in shares of Clorox by 9.9% during the third quarter. Lindbrook Capital LLC now owns 977 shares of the company’s stock worth $159,000 after purchasing an additional 88 shares in the last quarter. Finally, Houlihan Financial Resource Group Ltd. purchased a new position in shares of Clorox in the third quarter valued at approximately $201,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms have issued reports on CLX. Evercore ISI increased their target price on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. JPMorgan Chase & Co. lifted their target price on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. Barclays increased their price target on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research report on Wednesday, February 5th. Finally, Royal Bank of Canada reissued a “sector perform” rating and set a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. Three investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $159.62.

Get Our Latest Analysis on CLX

Clorox Trading Up 1.8 %

Shares of Clorox stock opened at $151.11 on Monday. The company has a fifty day simple moving average of $155.65 and a 200-day simple moving average of $160.47. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The stock has a market cap of $18.61 billion, a price-to-earnings ratio of 41.29, a PEG ratio of 2.62 and a beta of 0.45.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the firm earned $2.16 earnings per share. On average, equities analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.23%. The ex-dividend date is Wednesday, April 23rd. Clorox’s dividend payout ratio (DPR) is 133.33%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Recommended Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.